CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 2	2025-12-05		NCT06758700

Clinical trials